Compare · ISPR vs RGC
ISPR vs RGC
Side-by-side comparison of Ispire Technology Inc. (ISPR) and Regencell Bioscience Holdings Limited (RGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ISPR and RGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $4.02B, about 49.7x ISPR ($80.9M).
- ISPR has been more active in the news (2 items in the past 4 weeks vs 1 for RGC).
- ISPR has more recent analyst coverage (2 ratings vs 0 for RGC).
- Company
- Ispire Technology Inc.
- Regencell Bioscience Holdings Limited
- Price
- $1.42+2.16%
- $9.62+3.05%
- Market cap
- $80.9M
- $4.02B
- 1M return
- -
- +63.52%
- 1Y return
- -
- -46.48%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2023
- 2021
- News (4w)
- 2
- 1
- Recent ratings
- 2
- 0
Latest ISPR
- IKE Tech Launches IKE 2.0 to Bring Continuous Compliance to Regulated Products
- Ispire Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Ispire Technology Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Ispire Technology Inc. Reports Fourth Quarter and Fiscal Year 2026 Financial Results
- SEC Form 10-K filed by Ispire Technology Inc.
- Ispire Technology Inc. Schedules Fiscal Fourth Quarter and Full Year 2026 Earnings Conference Call
- Ispire Technology Inc. Appoints Steven Przybyla as President
- Ispire Technology Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- Director Cox Brent was granted 53,555 shares, increasing direct ownership by 62% to 139,863 units (SEC Form 4)
- Director Burch Christopher Robert was granted 45,760 shares, increasing direct ownership by 59% to 122,944 units (SEC Form 4)
Latest RGC
- SEC Form 20-F filed by Regencell Bioscience Holdings Limited
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited